1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Summary of clinical and lesion characteristics
Age/SexClinical HistoryTreatmentFistular FormationFlap SurgeryInfectionInitial SiteRebleedingRecurrence SiteInterval between Two EventsClinical Course
62/MEsophageal ca, Lt supraclavicular lymphadenopathyRTx, I & D(2)YesNoYesLt mid CCAYesProximal end of the stent margin10 daysNo recurrent hemorrhage on 2 months F/U
50/MNasopharyngeal caRTx(2), skull base op. w ND (Rt), PMMC flap, free flap, I & DYesUnfavorable resultYesRt carotid bulbYesProximal end of the stent margin44 daysPermanent carotid arterial occlusion for recurrent bloody sputum after the second stent placement, death after 8 months
67/MLaryngeal caRTx, TL w both ND several flap surgeryYesFavorable resultYes, streptococcusLt mid CCANoN/AN/ADeath 1 month later, no recurrent hemorrhage
64/MLaryngeal caRTx,(2) TL w both NDNoNoNoRt distal CCAYesRt ECA branch3 daysDischarge in stable condition 2 weeks later and lost F/U
69/MLaryngeal caRTx, TL w both ND, PMMCYesUnfavorable resultYesRt distal CCAYesDistal end of the stent margin23 daysDischarge for palliative care and lost F/U
55/FHypopharyngeal caRTx, TLPE w ND(Rt)YesUnfavorable resultYes, KlebsiellaLt distal CCAYesDistal end of the stent margin11 daysDischarge for palliative care and lost F/U
80/MHypopharyngeal caRTx(2)NoNoNoRt mid CCAYesLt mid CCA40 daysDeath from sepsis 10 days after the second stent placement
  • Note:—Ca indicates cancer; CCA, common carotid artery; ECA, external carotid artery; F/U, follow-up; I&D, incision and drainage; TLPE, total laryngopharyngoesophagectomy; Lt, left; mid, middle; N/A, not applicable; ND, neck dissection; op, operation; PMMC, pectoralis major myocutaneous; Rt, right; RTx, radiotherapy; TL, total laryngectomy.